360Dx

NorthShore Enlists Ambry Genetics for Whole-Exome Sequencing

Sep 12, 2017

This story has been updated to reflect new information from NorthShore regarding its alliance with Invitae.

CHICAGO (GenomeWeb) – NorthShore University HealthSystem is enlisting Ambry Genetics to offer genetic testing and research opportunities, the two entities announced today.

Under the new partnership, Aliso Viejo, California-based Ambry Genetics will provide whole-exome sequencing for 10,000 patients enrolled in NorthShore's Genomic Health Initiative.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

NorthShore Enlists Ambry Genetics for Whole-Exome Sequencing

To read the full story....

Breaking News

Natera Revenues Grow 35 Percent in Q4

NantHealth Q4 Revenues Flat From Year Ago

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

Oncocyte Closes Second and Final Investment in Razor Genomics Acquisition

Biocartis Reports 15 Percent Rise in 2020 Revenues

Featured White Papers

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

What's Popular?

AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter

SARS-CoV-2 Test Pooling Studies Offer Insights for Implementing, Optimizing Approaches

NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

Hong Kong Team Develops New Prostate Cancer Test Using Spermine

Sponsorships